Every amino acid except glycine has a handedness. The same atoms, the same bonds, the same molecular weight — but arranged in three-dimensional space as two non-superimposable mirror images, the way a left hand and a right hand are built from the same fingers in the same order yet cannot be laid one upon the other. Chemists call these enantiomers. They label them L and D, from the Latin laevus and dexter. Left and right. And then there is the fact, so fundamental it can feel like a law of nature rather than an accident, that every living thing on this planet — every bacterium, every sequoia, every human cell — builds its proteins exclusively from L-amino acids. This is called homochirality, and it is one of the oldest choices in biology. It was made before DNA, before the genetic code, before the first true cell. Something, somewhere, in the prebiotic chemistry of the early Earth, selected L over D, and every organism since has inherited that selection without exception.
Why left? No one knows. There are hypotheses. One traces the asymmetry to the weak nuclear force, which violates parity — it treats left and right differently at the subatomic level, introducing a vanishingly small energetic preference for L-amino acids over D. A preference so tiny it should be undetectable, except that over millions of years, in a system with autocatalytic amplification, a bias of one part in ten billion can become absolute. Another hypothesis requires no physics at all: a chance event, a single pool of prebiotic soup that happened to crystallize on the L side, amplified by positive feedback until the mirror world was locked out. Either way, the result is the same. Life is left-handed. The right-handed forms exist — they can be synthesized, they appear in meteorites, they are chemically indistinguishable in every achiral test — but biology does not use them. They are invisible to it. Enzymes evolved over four billion years to recognize the L configuration simply do not bind the D.
· · ·
Among the twenty standard amino acids, cysteine is singular. It is the only one that carries a sulfhydryl group — a sulfur atom bonded to hydrogen at the tip of its side chain. This sulfur is not decorative. It is the chemical basis of two systems so essential that their failure is incompatible with complex life. The first is glutathione, a tripeptide built from cysteine, glutamate, and glycine, which functions as the cell’s primary antioxidant — a reservoir of reducing power that neutralizes reactive oxygen species before they can damage DNA, lipids, and proteins. The second is iron-sulfur clusters: small inorganic cofactors in which iron atoms are coordinated by sulfur atoms derived from cysteine, forming structures of extraordinary antiquity. Iron-sulfur clusters predate life itself. They likely catalyzed reactions at hydrothermal vents before anything resembling a cell existed. Today they are embedded in the mitochondrial electron transport chain — Complexes I, II, and III — where they pass electrons one at a time down the energy gradient that powers cellular respiration. They are also required for DNA replication, DNA repair, and RNA processing. Without iron-sulfur clusters, a cell cannot breathe, cannot copy its genome, cannot maintain its own integrity.
Cancer cells are hungry for cysteine. This is not incidental to their biology but central to it. Rapid proliferation generates enormous amounts of reactive oxygen species as a byproduct of accelerated metabolism, and to survive this oxidative burden cancer cells must produce correspondingly enormous amounts of glutathione. To make glutathione they need cysteine. To get cysteine they overexpress a membrane transporter — a protein embedded in the cell surface whose job is to pull cysteine from the surrounding environment into the cell’s interior. They build more doors. They open them wider. They import cysteine as fast as they can.
· · ·
In 2025, Joséphine Zangari, working in the laboratories of Jean-Claude Martinou at the University of Geneva and Roland Lill at the University of Marburg, published a finding in Nature Metabolism that is quiet in presentation and startling in implication. D-cysteine — the mirror image of L-cysteine, the form that biology does not use — selectively kills certain cancer cells.
The mechanism begins at the door. The transporter that cancer cells overexpress to feed their cysteine hunger cannot distinguish between L-cysteine and D-cysteine. This is not surprising, because the transporter evolved to recognize cysteine by its size, charge, and sulfhydryl group — properties that are identical in both enantiomers. It evolved in a world where only L-cysteine existed. There was no selection pressure to develop stereospecificity, because there was never a D-cysteine molecule to reject. The transporter imports whatever fits through the door. And D-cysteine fits.
Inside the cell, the mirror ceases to be invisible. D-cysteine binds to NFS1, the mitochondrial enzyme cysteine desulfurase, which is responsible for extracting sulfur from L-cysteine and transferring it to the scaffold proteins that assemble iron-sulfur clusters. NFS1 evolved to work with L-cysteine. It can bind D-cysteine — the sulfur is in the right place, the overall shape is close enough — but it cannot process it. D-cysteine inhibits NFS1 the way a wrong key, inserted into a lock, prevents the right key from entering. The enzyme stalls. Iron-sulfur cluster biosynthesis stops.
· · ·
What follows is a cascade. Without new iron-sulfur clusters, the mitochondrial electron transport chain degrades. Complexes I, II, and III lose their cofactors and cannot pass electrons. Cellular respiration collapses. ATP production falls. Simultaneously, the enzymes that depend on iron-sulfur clusters for DNA replication and repair begin to fail. Damage accumulates in the genome. The cell cycle halts. The cancer cell, which was dividing rapidly and importing cysteine voraciously to sustain that division, starves. Not from lack of food in the conventional sense, but from a deeper starvation — the inability to build the ancient inorganic structures that sit at the foundation of aerobic metabolism.
In mice bearing aggressive triple-negative breast tumors, D-cysteine dramatically slowed tumor growth. The mice showed no significant side effects. Healthy tissue was unharmed. And the reason for this selectivity is precise and almost mechanical in its logic: healthy cells express the cysteine transporter at normal levels. They import some D-cysteine, but not enough to overwhelm NFS1. The residual enzyme activity is sufficient to maintain iron-sulfur cluster production. Cancer cells, with their overexpressed transporters, their wide-open doors, flood themselves with D-cysteine. They import the mirror in quantities that their mitochondrial machinery cannot survive.
Zangari and her colleagues confirmed this with a decisive experiment. When they artificially forced healthy cells to overexpress the same transporter, those cells became vulnerable to D-cysteine. The selectivity was not intrinsic to cancer biology in any deep sense. It was entirely a function of the door. Whatever opens the door wide enough, dies.
· · ·
There is something here that extends beyond pharmacology. The competitive advantage of a cancer cell — its accelerated metabolism, its glutathione production, its ability to survive oxidative stress that would kill a normal cell — depends on importing more cysteine than its neighbors. The transporter overexpression is not a defect. It is an adaptation. It is what makes the cancer cell successful. And it is precisely this adaptation, this specific advantage, that creates the attack surface through which D-cysteine enters. The strength is the vulnerability. The door that feeds the cell is the same door through which the mirror walks in.
This is a pattern that appears elsewhere in biology and beyond it: the mechanisms that confer advantage in one context create exposure in another. Antibiotic resistance genes that protect a bacterium also impose a metabolic cost that makes it less fit when the antibiotic is removed. Thick castle walls that repel invaders also trap the inhabitants if the food supply is cut. The overexpression of a nutrient transporter that lets a cancer cell outcompete its neighbors for cysteine also lets it import, without discrimination, the one form of cysteine that will shut down its mitochondria. Competitive advantages are not free. They are specific, and their specificity can be turned.
· · ·
What stays with me is the depth of the timescale. Homochirality was established roughly four billion years ago, in chemistry that predated cells, predated genes, predated anything we would recognize as alive. It was a choice — or an accident, or a consequence of a subatomic asymmetry in the weak force — that locked all subsequent biology into the L configuration. D-amino acids were excluded. They persisted in the abiotic world, in meteorites and laboratory syntheses, but biology had no use for them. They were the road not taken.
Four billion years later, a research group in Geneva finds that one of these excluded molecules, D-cysteine, can exploit a vulnerability in cancer cells that arises specifically because those cells are too successful at importing the L form. The mirror that biology rejected at the origin of life becomes, in 2025, a potential therapeutic agent. Not because it was designed to kill cancer. It was not designed at all. It is simply the other hand, the unchanged reflection, the molecule that has existed since the beginning in exact and useless correspondence with its twin. What changed is not the mirror. What changed is that cancer, through its own metabolic greed, built a door that does not check for handedness.
The iron-sulfur clusters that D-cysteine disrupts are themselves older than life. They formed spontaneously at hydrothermal vents, catalyzing reactions in a world without cells, without enzymes, without DNA. Life adopted them. It built an entire respiratory apparatus around them. It built NFS1 to maintain them. And now, billions of years later, that maintenance enzyme — shaped by evolution to fit L-cysteine and only L-cysteine — encounters the mirror for the first time in meaningful concentrations inside a living cell, and fails. The enzyme is not broken. It was never built to handle this. No enzyme was. The entire enzymatic repertoire of terrestrial life is a catalogue of L-specific machinery, and D-cysteine moves through it like a word from a language that was excluded from the dictionary before the dictionary was written.
The mirror was always there. It is as old as chirality itself, as old as the carbon atom’s tetrahedral geometry, as old as the first amino acid that condensed in an interstellar cloud. It did not change. It did not evolve. It did not adapt. It simply waited — not with patience, because it is a molecule and molecules do not wait, but with the permanence of something that has no reason to decay. And now it enters through doors that cancer cells built for a different purpose entirely, carrying sulfur that looks right but sits wrong in the active site of an enzyme that has never, in four billion years, had to tell the difference.